SCHEMBL14582925

SCHEMBL14582925

CCCN(CCC)c1cnc2ccccc2n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.44
▸ NPC1 O15118 7/20 0.42
▸ RAB9A P51151 7/20 0.42
▸ KDM4E B2RXH2 5/20 0.42
▸ MAPT P10636 4/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ HPGD P15428 2/20 0.42
▸ HCAR3 P49019 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ AGTR1 P30556 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ HTT P42858 3/20 0.40
▸ ATM Q13315 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ HTR3A P46098 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28585105 0.85 PDE10A (0.47) PDE10ANPC1RAB9AKDM4EMAPT
Hydrochloric Acid SCHEMBL28608866 0.84 PDE10A (0.46) PDE10ANPC1RAB9AKDM4EMAPT
SCHEMBL26149036 0.79 ESR2 (0.41) PDE10AMAPTALDH1A1HCAR3MEN1
SCHEMBL13701721 0.78 NCF1 (0.60) NPC1RAB9AMAPTHCAR3MEN1
SCHEMBL26677368 0.78 KDM4E (0.43) PDE10ANPC1RAB9AKDM4EMAPT
SCHEMBL7048629 0.75 NCF1 (0.55) PDE10ANPC1RAB9AKDM4EMAPT
SCHEMBL9131395 0.74 CYP1A2 (0.50) RAB9AKDM4EMAPTALDH1A1HPGD
Hydrochloric Acid SCHEMBL28590788 0.73 NCF1 (0.53) PDE10ANPC1RAB9AKDM4EMAPT
SCHEMBL28679814 0.72 KDM4E (0.45) PDE10ANPC1RAB9AKDM4EMAPT
SCHEMBL5435508 0.72 RAB9A (0.49) PDE10ANPC1RAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007027532-A2 NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT MERCK & CO., INC. (US) 2007-03-08 — — WO disclosed
Send feedback